Although there are no data to confirm that MAP7 and ZNF429 are relationship to obesity or T2DM, we believe that they may be closely related to the pathogenesis of O‐T2DM due to their mutations in the exon region and their significant changes in transcriptome expression levels. Here, MAP7 is linked to obesity disorder.